FACTS ABOUT NEW ADVANCEMENTS IN BRD4 INHIBITION THERAPY ABBV-744 REVEALED

In Section A, individuals will receive different doses and schedules of oral ABBV-744 pill to discover Protected dosing regimen. More members will likely be enrolled on the identified monotherapy dosign routine. In Segment B, members will obtain oral ruxolitinib and ABBV-744 is going to be presented as "include-on" therapy. In Phase C, individuals